Therakind attends Digital BIO 2020

Written By Stephen Douglas

1 June 2020 - Therakind Limited, a specialty pharmaceutical company focused on developing niche medicines for difficult-to-treat patient groups, notes that CEO, Susan Conroy, will be attending Digital BIO 2020 on 8-11 June 2020.  https://www.bio.org/press-release/2020-bio-international-convention-now-fully-digital

BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centres and related organizations across the United States and in more than 30 other nations.

Enquiries:

Therakind Limited 
Susan Conroy, Chief Executive Officer
Sam Race, Finance Director

Tel: +44 (0)208 346 6035

Email: admin@therakind.com 

Stephen Douglas
Previous

Therakind acquires IP to novel dry powder nasal device, DriDose®
Next

Therakind enters exclusive distribution partnership with BioJam Holding Group